Journal of Thoracic Disease

Scope & Guideline

Unveiling breakthroughs in pulmonary and respiratory medicine.

Introduction

Immerse yourself in the scholarly insights of Journal of Thoracic Disease with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2072-1439
PublisherAME PUBLISHING COMPANY
Support Open AccessNo
CountryHong Kong
TypeJournal
Convergefrom 2009 to 2024
AbbreviationJ THORAC DIS / J. Thorac. Dis.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressFLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA

Aims and Scopes

The Journal of Thoracic Disease primarily focuses on advancing the understanding and treatment of thoracic diseases, particularly those affecting the lungs and chest area. The journal encompasses a wide range of topics, including surgical techniques, innovative therapies, and the underlying pathophysiology of thoracic conditions.
  1. Lung Cancer Research:
    The journal publishes extensively on various aspects of lung cancer, including diagnostic techniques, treatment modalities, and prognostic factors. This includes research on surgical interventions, targeted therapies, and immunotherapy.
  2. Surgical Innovations and Techniques:
    There is a strong emphasis on the development and evaluation of minimally invasive surgical techniques, including video-assisted thoracoscopic surgery (VATS) and robotic-assisted surgeries. The journal also explores advancements in surgical tools and techniques to improve patient outcomes.
  3. Pulmonary Diseases and Disorders:
    Research on chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung diseases, is prominently featured. The journal includes studies on pathophysiology, management strategies, and rehabilitation approaches.
  4. Transplantation and Thoracic Surgery:
    The journal addresses challenges and advancements in lung transplantation, including donor management, post-operative care, and the management of complications post-transplant. It also covers surgical approaches for other thoracic conditions.
  5. Diagnostic Imaging and Radiomics:
    A focus on the use of advanced imaging techniques, including radiomics and artificial intelligence, to enhance diagnostic accuracy and predict outcomes in lung diseases. Articles often discuss the role of imaging in guiding treatment decisions.
  6. Interventional Pulmonology:
    The journal covers the latest developments in interventional pulmonology, including bronchoscopic techniques for diagnosis and treatment of pulmonary conditions, showcasing innovative therapeutic approaches.
The Journal of Thoracic Disease has recently witnessed a surge in interest in several key areas that reflect the evolving landscape of thoracic medicine. These emerging themes highlight innovative research and advancements in treatment and diagnosis.
  1. Immunotherapy and Targeted Therapies:
    There is a growing focus on the role of immunotherapy and targeted therapies in treating lung cancer. Studies investigating biomarkers for treatment response and the efficacy of combination therapies are increasingly prevalent.
  2. Artificial Intelligence and Machine Learning:
    Emerging research on the application of artificial intelligence and machine learning in diagnostics and treatment planning represents a significant trend. This includes using AI for image analysis and predicting patient outcomes.
  3. Enhanced Recovery After Surgery (ERAS) Protocols:
    The adoption of ERAS protocols in thoracic surgery is a trending topic, reflecting a shift towards optimizing postoperative recovery and minimizing complications through multidisciplinary approaches.
  4. Radiomics and Advanced Imaging Techniques:
    Research utilizing radiomics and advanced imaging modalities for better diagnosis and treatment planning in lung diseases is on the rise, indicating a trend towards precision medicine.
  5. Chronic Respiratory Disease Management:
    An increased emphasis on comprehensive management strategies for chronic respiratory diseases, including COPD and asthma, is evident, with articles focusing on rehabilitation and patient-centered care.

Declining or Waning

While the Journal of Thoracic Disease maintains a broad focus, certain themes have shown a decline in publication frequency or interest among researchers. This may reflect shifting priorities in thoracic medicine and emerging trends that have gained more traction.
  1. Traditional Surgical Approaches:
    There has been a noticeable decrease in research focused on traditional open surgical techniques, as the field shifts towards minimally invasive methods. This reflects a broader trend in thoracic surgery towards optimizing recovery and reducing complications.
  2. Less Emphasis on Chemotherapy Alone:
    The journal's publications on chemotherapy as a standalone treatment for lung cancer have waned, likely due to the increasing focus on combination therapies and immunotherapy, which are now considered more effective.
  3. Palliative Care Studies:
    Research specifically centered on palliative care approaches for thoracic diseases has seen less frequent publication, possibly overshadowed by advancements in curative treatments and more aggressive management strategies.
  4. General Anesthesia in Thoracic Surgery:
    There seems to be a decline in articles discussing general anesthesia techniques specifically for thoracic surgery, as more studies explore regional anesthesia and opioid-sparing strategies.
  5. Acute Respiratory Infections:
    Research on acute respiratory infections, while still relevant, appears to be less prominent as the journal shifts focus towards chronic conditions and long-term management strategies.

Similar Journals

Canadian Journal of Respiratory Critical Care and Sleep Medicine

Elevating standards in critical and sleep medicine.
Publisher: TAYLOR & FRANCIS INCISSN: 2474-5332Frequency: 4 issues/year

Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.

RESPIROLOGY

Unveiling Breakthroughs in Respiratory Health
Publisher: WILEYISSN: 1323-7799Frequency: 12 issues/year

RESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.

Respiratory Investigation

Exploring the depths of pulmonary innovations.
Publisher: ELSEVIERISSN: 2212-5345Frequency: 6 issues/year

Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.

CHEST

Connecting researchers and practitioners for impactful healthcare solutions.
Publisher: ELSEVIERISSN: 0012-3692Frequency: 12 issues/year

CHEST is a premier journal published by Elsevier, focusing on the vital fields of cardiology, critical care, and pulmonary medicine. Established in 1970, this esteemed journal has continually provided authoritative research, reviews, and clinical studies, catering to a global audience of healthcare professionals, researchers, and students. With an impressive impact factor, CHEST ranks in the top quartile (Q1) across its core categories according to the latest Scopus metrics, securing its position as a leading resource within cardiology (Rank #16), pulmonary (Rank #9), and critical care (Rank #8). Published quarterly, it offers a wealth of knowledge essential for advancing understanding and improving patient outcomes in these critical areas of healthcare. Researchers and practitioners are encouraged to submit their work, contributing to the ongoing discourse that shapes innovative practices and policies in respiratory and cardiovascular health.

THORACIC AND CARDIOVASCULAR SURGEON

Transforming patient care through cutting-edge research.
Publisher: GEORG THIEME VERLAG KGISSN: 0171-6425Frequency: 8 issues/year

THORACIC AND CARDIOVASCULAR SURGEON, published by GEORG THIEME VERLAG KG, is a prestigious journal dedicated to the fields of cardiology, cardiovascular surgery, and pulmonary medicine. Since its inception in 1973, the journal has served as a vital platform for disseminating cutting-edge research and innovative techniques, contributing significantly to advancements in patient care and surgical practices. With an emerging recognition evidenced by its category quartiles, ranking Q3 in Cardiology and Cardiovascular Medicine and Q2 in Surgery as of 2023, it positions itself as an essential resource for both clinicians and researchers alike. Although this journal does not currently offer Open Access options, it maintains a strong impact with Scopus rankings that highlight its relevance within the medicine and surgery disciplines. The journal is particularly committed to bridging the gap between theoretical research and practical application, making it crucial for professionals aiming to stay informed on the latest developments in thoracic and cardiovascular health. Join a community of scholars dedicated to excellence in these critical areas of medicine.

Indian Journal of Thoracic and Cardiovascular Surgery

Illuminating Paths in Cardiovascular and Pulmonary Research
Publisher: SPRINGER INDIAISSN: 0970-9134Frequency: 4 issues/year

Indian Journal of Thoracic and Cardiovascular Surgery, published by SPRINGER INDIA, serves as a vital platform for the dissemination of innovative research and clinical advancements in the fields of cardiology, cardiovascular medicine, pulmonary, and respiratory medicine. With a rich history dating back to 1982 and spanning multiple years through to 2024, this journal aims to provide a comprehensive view of both theoretical and practical aspects of thoracic and cardiovascular surgery. Although it currently holds a Q3 quartile ranking across various relevant categories, researchers and practitioners can benefit from its insightful articles that contribute to ongoing discussions and advancements in these critical medical areas. The journal does not offer open access presently, yet it is accessible through major academic databases, providing valuable resources for professionals and students keen on enhancing their understanding and expertise. In a rapidly evolving field marked by technological advancements and novel research, the Indian Journal of Thoracic and Cardiovascular Surgery remains integral to fostering collaboration and education among its audience.

Lung India

Elevating standards in lung disease management.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-2113Frequency: 6 issues/year

Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.

RESPIRATION

Exploring Innovations in Respiratory Research
Publisher: KARGERISSN: 0025-7931Frequency: 12 issues/year

RESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.

Annals of Thoracic Medicine

Fostering collaboration in the pursuit of thoracic excellence.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1817-1737Frequency: 4 issues/year

Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.

Indian Journal of Respiratory Care

Empowering Knowledge in Respiratory Care
Publisher: JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTDISSN: 2277-9019Frequency: 4 issues/year

Welcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.